Keyphrases
Prostate Cancer
100%
ACK1
59%
Castration-resistant Prostate Cancer
45%
Phosphorylation
44%
TNK2
42%
Androgen Receptor
42%
Tumor
40%
Clear Cell Renal Cell Carcinoma (ccRCC)
38%
Essential Pathway
38%
Transcriptomic Characterization
38%
Epigenetics
38%
Progression Markers
38%
Ultrasound-guided
38%
Endobronchial Ultrasound
38%
Tumor Cells
34%
Tyrosine Kinase
30%
Non-small Cell Lung Cancer (NSCLC)
28%
Acetylation
26%
Fine-needle Aspiration
25%
Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA)
24%
Programmed Death-ligand 1 (PD-L1)
24%
Cytomorphology
22%
Spatial Transcriptomics
22%
Immunohistochemistry
22%
Reporting System
21%
Data Systems
21%
Therapeutic Vulnerabilities
20%
Clinically Significant Prostate Cancer
20%
Conflict of Interest
19%
Plasma Cell Neoplasm
19%
Cytological Samples
19%
BerEP4
19%
Androgen Production
19%
Histone H2A
19%
Potential Conflict
19%
MOC31
19%
Urinary Bladder Mass
19%
PARP Inhibitor (PARPi)
19%
Insurance Medicine
19%
Transbronchial Aspiration
19%
Advanced Prostate Cancer
19%
Clinical Proteomic Tumor Analysis Consortium
19%
National Cancer Institute
19%
Declare
19%
Competing Interests
19%
Specific Antibodies
19%
Bladder Mass
19%
Epithelial Cell Adhesion Molecule (EpCAM)
19%
Vulnerability
19%
Cdc42
19%
Medicine and Dentistry
Prostate Cancer
79%
Endobronchial Ultrasonography
38%
Immunohistochemistry
33%
Biopsy Technique
31%
Neoplasm
30%
Malignant Neoplasm
25%
Cytotechnology
25%
Fine-Needle Aspiration
25%
Biological Marker
24%
Non Small Cell Lung Cancer
23%
Transbronchial Aspiration
22%
Tumor Cell
22%
Glycan
22%
Lung Cancer
19%
Follicular Dendritic Cell Sarcoma
19%
PARP1
19%
Homologous Recombination
19%
Clear Cell Renal Cell Carcinoma
19%
Epithelial Cell Adhesion Molecule
19%
Plasmacytoma
19%
Bladder
19%
Recombination Repair
19%
Transcriptomics
19%
Homeostasis
19%
Histone H3
19%
Androgen Receptor
19%
Molecular Marker
19%
Proteomics
19%
Mass Spectrometry Imaging
19%
Histopathology
19%
Programmed Death 1 Ligand 1
19%
Metastatic Carcinoma
19%
Artificial Intelligence
19%
Analysis of Variance
19%
Effusion
14%
Carcinoma
14%
PARP Inhibitor
12%
Matrix-Assisted Laser Desorption-Ionization
12%
Adenocarcinoma
10%
Hematopoietic System Malignancy
9%
Poly ADP Ribose Polymerase
9%
Health Care Cost
9%
Lung
9%
Mediastinum Mass
9%
Cytopathology
9%
Odds Ratio
9%
Epidermal Growth Factor Receptor
8%
Reactive Oxygen Species
8%
Anaplastic Lymphoma Kinase
8%
Programmed Death-Ligand 1
8%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
45%
Epigenetics
38%
Kinase
29%
Phosphotransferase
29%
Acetylation
25%
Polysaccharide
25%
Tyrosine Kinase
24%
Receptor Tyrosine Kinase
24%
Matrix-Assisted Laser Desorption/Ionization
22%
Cancer Cell
20%
Enhancer Region
20%
Transcriptomics
19%
ATP Synthase
19%
Histone H2A
19%
Ferroxidase
19%
Ceruloplasmin
19%
Androgen Synthesis
19%
Troponin I
19%
CDC42
19%
Alpha Chain
19%
HOXB13
19%
Immune Checkpoints
19%
C-Terminus
19%
Enzyme
19%
Histone H3
19%
Homeostasis
19%
Mass Spectrometry Imaging
19%
Artificial Intelligence
19%
Facilitated Diffusion
19%
Enzalutamide
12%
Carcinogenesis
11%
Tumor Progression
11%
Mitophagy
11%
Non-Receptor Tyrosine Kinase
11%
Tyrosine
9%
Mitochondrion
7%
Troponin
7%
T Cell
6%
Mesenchymal-Epithelial Transition
6%
PBRM1
6%
BAP1
6%
Tamsulosin
6%
Proteogenomics
6%
Eosin
6%
Immunocompetent Cell
6%
Clinical Trial
6%
Extracellular Matrix Proteins
6%
Scleroprotein
6%
Fucosylation
6%
Fucose
6%